SCHEMBL25349138

SCHEMBL25349138

COc1ccc(O)c(C(=O)Nc2cc(Br)c(O)c(Br)c2)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TMPRSS4 Q9NRS4 3/20 0.64
▸ P2RX1 P51575 2/20 0.64
▸ PLAU P00749 2/20 0.62
▸ FADS1 O60427 2/20 0.61
▸ F2 P00734 1/20 0.60
▸ F10 P00742 1/20 0.60
▸ PLAT P00750 1/20 0.60
▸ NPC1 O15118 6/20 0.53
▸ MEN1 O00255 6/20 0.53
▸ KMT2A Q03164 6/20 0.53
▸ MAPT P10636 3/20 0.53
▸ HSP90AA1 P07900 1/20 0.53
▸ PKM P14618 1/20 0.53
▸ PAX8 Q06710 1/20 0.53
▸ NPSR1 Q6W5P4 1/20 0.53
▸ RAB9A P51151 5/20 0.52
▸ CASP3 P42574 1/20 0.52
▸ SENP7 Q9BQF6 1/20 0.52
▸ SENP6 Q9GZR1 1/20 0.52
▸ PNLIP P16233 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25348129 0.89 KLKB1 (0.61) TMPRSS4P2RX1PLAUFADS1F2
SCHEMBL25347627 0.83 FADS1 (0.68) TMPRSS4P2RX1PLAUFADS1F2
SCHEMBL330733 0.82 FADS1 (0.78) TMPRSS4P2RX1PLAUFADS1F2
SCHEMBL330534 0.80 P2RX1 (0.79) TMPRSS4P2RX1PLAUFADS1F2
SCHEMBL330568 0.79 P2RX1 (0.71) TMPRSS4P2RX1PLAUFADS1F2
SCHEMBL1436731 0.79 P2RX1 (0.57) TMPRSS4P2RX1PLAUFADS1F2
SCHEMBL130066 0.78 TMPRSS4 (1.00) TMPRSS4P2RX1PLAUFADS1F2
SCHEMBL25349562 0.78 TMPRSS4 (0.72) TMPRSS4P2RX1MEN1KMT2A
SCHEMBL11594959 0.76 P2RX1 (0.65) P2RX1PLAUFADS1NPC1MEN1
SCHEMBL8401870 0.76 TMPRSS4 (0.81) TMPRSS4P2RX1PLAUFADS1F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023149548-A1 NOVEL PHARMACEUTICAL COMPOSITION 国立大学法人富山大学 2023-08-10 — — WO disclosed
Send feedback